Cancer Family
Malignant Respiratory System Neoplasm
CI-CAN-00000249Explore in graph →
2,650 active trials51 approved drugs619 evidence items
- NCIt
- C4571
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000249Explore in graph →
Clinical trials
11,128 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,492)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06484816 | TGRX-1942 Chinese Phase I for Advanced Solid Tumor And/or Relapsed/Refractory Hematologic Malignancies | recruiting | Phase 1 | 90 | Shenzhen TargetRx Co., Ltd.INDUSTRY | 1 | Feb 24, 2025 | clinicaltrials |
| NCT05281406 | Additional Chemotherapy for EGFRm Patients with the Continued Presence of Plasma CtDNA EGFRm At Week 3 After Start of Osimertinib 1st-line Treatment (PACE-LUNG) | recruiting | Phase 2 | 50 | Goethe UniversityOTHER | 1 | Feb 21, 2025 | clinicaltrials |
| NCT06771960 | Association Between RVT and Prognosis After Neoadjuvant Targeted Therapy in EGFR NSCLC | recruiting | — | 120 | Guangdong Provincial People's HospitalOTHER | 1 | Feb 21, 2025 | clinicaltrials |
| NCT06833632 | Detection of Circulating Tumour Cells, Spread Through Air Space in Patients With Lung Cancer | recruiting | — | 100 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 1 | Feb 19, 2025 | clinicaltrials |
| NCT02622581 | Clinical Research Platform Into Molecular Testing, Treatment and Outcome of (Non-)Small Cell Lung Carcinoma Patients(CRISP) | recruiting | — | 12,400 | AIO-Studien-gGmbHOTHER | 1 | Feb 18, 2025 | clinicaltrials |
| NCT06272864 | BostonGene and Exigent Genomic INsight Study(BEGIN) | recruiting | — | 400 | BostonGeneINDUSTRY | 1 | Feb 17, 2025 | clinicaltrials |
| NCT06458894 | Research on Building and Application of Internet-based Home Pre-rehabilitation Model for Lung Surgery Patients. | recruiting | N/A | 100 | The Fourth Affiliated Hospital of Zhejiang University School of MedicineOTHER | 1 | Feb 17, 2025 | clinicaltrials |
| NCT03647098 | Survival Outcomes of Lung Cancer(Soul) | recruiting | — | 20,000 | Hunan Province Tumor HospitalOTHER | 1 | Feb 14, 2025 | clinicaltrials |
| NCT04616209 | Allogeneic PB103 (NK Cells) Therapy in Non-small Cell Lung Cancer (NSCLC) Patients | recruiting | Phase 1 / Phase 2 | 24 | Precision Biotech Taiwan Corp.INDUSTRY | 1 | Feb 14, 2025 | clinicaltrials |
| NCT05104515 | First-in-human Study of OVM-200 as a Therapeutic Cancer Vaccine | recruiting | Phase 1 | 36 | Oxford Vacmedix UK Ltd.INDUSTRY | 1 | Feb 14, 2025 | clinicaltrials |
| NCT05669430 | A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies | recruiting | Phase 1 / Phase 2 | 365 | GV20 TherapeuticsINDUSTRY | 1 | Feb 13, 2025 | clinicaltrials |
| NCT05257967 | CSF Analysis in EGFR Mutant Non-Small Cell Lung Cancer With Leptomeningeal Disease | recruiting | N/A | 10 | British Columbia Cancer AgencyOTHER | 1 | Feb 11, 2025 | clinicaltrials |
| NCT06613009 | Study of IBI3009 in Participants with Unresectable, Metastatic or Extensive-Stage Small Cell Lung Cancer | recruiting | Phase 1 | 190 | Innovent Biologics (Suzhou) Co. Ltd.INDUSTRY | 2 | Feb 11, 2025 | clinicaltrials |
| NCT06714708 | Low Dose Radiotherapy Combined With Sintilimab and Chemotherapy as Neoadjuvant Therapy for Stage II-III NSCLC | recruiting | Phase 2 | 86 | Anhui Provincial Cancer HospitalOTHER | 1 | Feb 10, 2025 | clinicaltrials |
| NCT06818149 | Biomarkers for Clinical Classification and Outcomes of Immune Checkpoint Inhibitor-Related-Related Myocarditis in Lung Cancer | recruiting | — | 50 | Shanghai Chest HospitalOTHER | 1 | Feb 10, 2025 | clinicaltrials |
| NCT04886401 | Retrospective Observational Study on Prediction of Response to PD-1 Immunotherapy in Patients with NSCLC(PREDICTION) | recruiting | — | 50 | University Hospital, BrestOTHER | 1 | Feb 6, 2025 | clinicaltrials |
| NCT06082492 | The Beneficial Value of PET/CT in the Follow-up of Stage III Non-small Cell Lung Cancer Patients(NVALT31-PET) | recruiting | N/A | 690 | Radboud University Medical CenterOTHER | 1 | Feb 5, 2025 | clinicaltrials |
| NCT06807307 | Transcriptional Framework for the Molecular Diagnosis of Response to Immunotherapy in Lung Cancer With Agnostic Potential(KEAPnes) | recruiting | — | 256 | Regina Elena Cancer InstituteOTHER | 1 | Feb 4, 2025 | clinicaltrials |
| NCT03740503 | Genomic Investigation of Unusual Responders(GENIUS) | recruiting | — | 100 | University Health Network, TorontoOTHER | 1 | Jan 31, 2025 | clinicaltrials |
| NCT05819346 | Digital Lifestyle Intervention for Lung Cancer Survivors(QUALUCA) | recruiting | N/A | 88 | Kai-Uwe Schmitt, PhD, MEng, ICIDOTHER | 1 | Jan 30, 2025 | clinicaltrials |
| NCT06341933 | Risk Factors for AKI in Patients Undergoing VATS for Pulmonary Resection | recruiting | — | 100 | Atatürk Chest Diseases and Chest Surgery Training and Research HospitalOTHER | 1 | Jan 30, 2025 | clinicaltrials |
| NCT05654675 | Evaluation of the Use of the FUR to Quantify Tumor Glucose Consumption in Oncologic PET | recruiting | — | 30 | Academisch Ziekenhuis MaastrichtOTHER | 1 | Jan 29, 2025 | clinicaltrials |
| NCT06630611 | Evaluation of a Pragmatic Approach to Adoptive Cell Therapy (ACT) Using an IL2 Analog (ANV419) vs High Dose IL2 After Tumor Infiltrating Lymphocytes (TIL) Therapy in Patients With Melanoma, NSCLC and Cervical Cancer (PragmaTIL)(PragmaTIL) | recruiting | Phase 2 | 40 | Vall d'Hebron Institute of OncologyOTHER | 1 | Jan 28, 2025 | clinicaltrials |
| NCT04324164 | Survival Outcome of EGFR-TKI in Uncommon EGFR Mutant Advanced NSCLC | recruiting | — | 800 | Hunan Province Tumor HospitalOTHER | 1 | Jan 27, 2025 | clinicaltrials |
| NCT05341557 | A Phase 1 Study of BPI-371153 in Subjects with Advanced Solid Tumors or Relapsed/Refractory Lymphoma | recruiting | Phase 1 | 110 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Jan 27, 2025 | clinicaltrials |
| NCT05504278 | Efficacy and Safety of IBI351 in Combination With Chemotherapy in Advanced Non-squamous Non-small Cell Lung Cancer Subjects With KRAS G12C Mutation | recruiting | Phase 1 | 144 | Innovent Biologics (Suzhou) Co. Ltd.INDUSTRY | 1 | Jan 27, 2025 | clinicaltrials |
| NCT06793813 | Cadonilimab in Patients (Pts) with Advanced Non-small Cell Lung Cancer (NSCLC) | recruiting | Phase 2 | 44 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Jan 27, 2025 | clinicaltrials |
| NCT06790797 | Investigating the Biomarkers in Tumor and Peripheral Blood to Evaluate the Efficacy of Cancer Immunotherapy in Chest Cancer Patients | recruiting | — | 50 | Zhao JunOTHER | 1 | Jan 24, 2025 | clinicaltrials |
| NCT06071013 | Nintedanib Plus EGFR TKI In EGFR-mutated Non-small Cell Lung Cancer Patients | recruiting | Phase 1 / Phase 2 | 20 | China Medical University HospitalOTHER | 1 | Jan 23, 2025 | clinicaltrials |
| NCT06758557 | A Study to Evaluate the Safety and Efficacy of HB0025 Injection in Patients With Advanced Solid Tumor | recruiting | Phase 1 / Phase 2 | 282 | Huabo Biopharm Co., Ltd.INDUSTRY | 1 | Jan 23, 2025 | clinicaltrials |
| NCT06788366 | AI-HOPE Lung Cancer: Building a Predictive Tool for Metastatic Lung Cancer | recruiting | — | 2,000 | IRCCS San RaffaeleOTHER | 1 | Jan 23, 2025 | clinicaltrials |
| NCT06786468 | Standard Care With or Without Early Palliative Care Provided by Palliative Care Specialist in Advanced Non-small Cell Lung Cancer Patients | recruiting | N/A | 104 | Mahidol UniversityOTHER | 1 | Jan 22, 2025 | clinicaltrials |
| NCT06684418 | Artificial Intelligence-based Model for the Prediction of Occult Lymph Node Metastasis and Improvement of Clinical Decision-making in Non-small Cell Lung Cancer | recruiting | — | 6,000 | Fudan UniversityOTHER | 1 | Jan 20, 2025 | clinicaltrials |
| NCT06667167 | First Line Therapy for Extensive SCLC Patients, Treated with Chemo+Keytruda Followed by Keytuda+Trodelvy | recruiting | Phase 2 | 21 | Nir PeledOTHER | 1 | Jan 17, 2025 | clinicaltrials |
| NCT06780826 | A Study on the Efficacy of Atezolizumab Combined with Chemotherapy | recruiting | — | 1,430 | Shanghai Pulmonary Hospital, Shanghai, ChinaOTHER | 1 | Jan 17, 2025 | clinicaltrials |
| NCT06778512 | LcProt: Proteomics Longitudinal Cohort Study on Lung Cancer | recruiting | — | 2,500 | The First Affiliated Hospital of Guangzhou Medical UniversityOTHER | 1 | Jan 16, 2025 | clinicaltrials |
| NCT06581419 | A Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors | recruiting | Phase 1 / Phase 2 | 78 | SUNHO（China）BioPharmaceutical CO., Ltd.INDUSTRY | 1 | Jan 15, 2025 | clinicaltrials |
| NCT06775275 | A Study of Adebrelimab in Combination with Chemo with or Without Bevacizumab Neoadjuvant Therapy for Resectable NSCLC | recruiting | Phase 2 | 60 | The First Affiliated Hospital of Guangzhou Medical UniversityOTHER | 1 | Jan 15, 2025 | clinicaltrials |
| NCT06467383 | A Study to Describe the Diagnostic and Therapeutic Path of Patients with NSCLC in Early Stage and Locally Advanced(Key-Early) | recruiting | — | 600 | MSD Italia S.r.l.INDUSTRY | 1 | Jan 14, 2025 | clinicaltrials |
| NCT06500312 | Decoding the Association of Imaging and Tumor Microenvironment in Lung Cancer Using Radiogenomic Approach（Radiogenomics-Lung） | recruiting | — | 150 | Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyOTHER | 1 | Jan 13, 2025 | clinicaltrials |
| NCT00682032 | The Effect of Beta-glucan in Non-Small Cell Lung Cancer | recruiting | N/A | 300 | University of LouisvilleOTHER | 1 | Jan 10, 2025 | clinicaltrials |
| NCT06422403 | A Value-Driven Study on Reducing Immune Checkpoint Inhibitor Dosing Frequency in Advanced Cancers(VALUE-CHECK) | recruiting | Phase 2 | 360 | National University Hospital, SingaporeOTHER | 1 | Jan 10, 2025 | clinicaltrials |
| NCT06768151 | A Clinical Trial of CEA Targeting CAR-T for CEA Positive Advanced Lung Cancer | recruiting | Phase 1 | 48 | Chongqing Precision Biotech Co., LtdINDUSTRY | 1 | Jan 10, 2025 | clinicaltrials |
| NCT06769295 | A Phase II Study of AK112 (PD1/VEGF Bispecific) in Combination with Chemotherapy in Patients with NSCLC | recruiting | Phase 2 | 28 | Sichuan UniversityOTHER | 1 | Jan 10, 2025 | clinicaltrials |
| NCT06769971 | Phase II Study of Ivonescimab and Cadonilimab in Combination with Chemotherapy in Patients with ES-SCLC | recruiting | Phase 2 | 80 | Sichuan UniversityOTHER | 1 | Jan 10, 2025 | clinicaltrials |
| NCT06090266 | A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents | recruiting | Phase 1 / Phase 2 | 168 | OncoResponse, Inc.INDUSTRY | 1 | Jan 7, 2025 | clinicaltrials |
| NCT06644066 | Partial Pressure of Oxygen Control Method in Identification of Intersegmental Plane | recruiting | N/A | 60 | Tang-Du HospitalOTHER | 1 | Jan 7, 2025 | clinicaltrials |
| NCT06480864 | Adebrelimab Plus Apatinib for Maintenance Therapy of Extensive Stage Small Cell Lung Cancer | recruiting | N/A | 38 | Yunpeng LiuOTHER | 1 | Jan 6, 2025 | clinicaltrials |
| NCT06528743 | Feasibility of Primer Shot Radiotherapy for Non-small Cell Lung Cancer - PRIMER(PRIMER) | recruiting | N/A | 34 | The Netherlands Cancer InstituteOTHER | 1 | Jan 6, 2025 | clinicaltrials |
Data updated 23 days agoSource updated Feb 24, 2025source: clinicaltrials